Cite

HARVARD Citation

    Denton, C. et al. (2023). Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis. Rheumatology. pp. 234-242. [Online]. 
  
Back to record